Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use
Today, a brief rundown of news from Praxis Precision Medicines and Bristol Myers Squibb, as well as updates from Denali Therapeutics, Crescent Biopharma and AstraZeneca that you may have missed. Shares of Praxis Precision Medicines surged roughly 40% …